For the quarter ending 2025-09-30, ACET made $29,221K in revenue. -$26,759K in net income. Net profit margin of -91.57%.
| Income Statement | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Research and development | 22,853 | 28,424 | ||
| General and administrative | 5,099 | 3,968 | ||
| Total operating expenses | 27,952 | 32,392 | ||
| Loss from operations | -27,952 | -32,392 | ||
| Interest income | 1,172 | 1,398 | ||
| Interest expense | 12 | 0 | ||
| Other expense, net | -64 | -223 | ||
| Loss before income tax provision | -26,856 | -31,217 | ||
| Income tax provision | 0 | 0 | ||
| Net loss | -26,856 | -31,217 | ||
| Unrealized gain on treasury securities, net of tax | 97 | -32 | ||
| Total other comprehensive income | 97 | -32 | ||
| Comprehensive loss | -26,759 | -31,249 | ||
| Earnings per share, basic, total | -0.29 | -0.34 | ||
| Earnings per share, diluted, total | -0.29 | -0.34 | ||
| Weighted average number of shares outstanding, basic, total | 91,086,464 | 91,085,506 | ||
| Weighted average number of shares outstanding, diluted, total | 91,086,464 | 91,085,506 | ||
Adicet Bio, Inc. (ACET)
Adicet Bio, Inc. (ACET)